NCT02879877View on ClinicalTrials.gov

A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 11, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

UCB7858

DRUG

Placebo

Trial Locations (1)

Unknown

Up0029 001, London

All Listed Sponsors
lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT02879877 - A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers | Biotech Hunter | Biotech Hunter